AHTA is made up of a multidisciplinary team with staff expertise in areas of health technology assessment (HTA), health economics, ethics, research synthesis, methodological research, guideline development, and research information technology management.

Photo of AHTA Director, Professor Tracy Merlin

Professor Tracy Merlin, Director

Tracy Merlin is the first Professor of Health Technology Assessment in Australia, having worked in this relatively new field for over 20 years.

She is the director and co-founder of AHTA at the University of Adelaide. In this role she leads a large and experienced team of researchers undertaking multi-million dollar applied research and evaluation activities on behalf of government and non-government agencies. This research directly informs health policy and clinical practice. The HTA arm of AHTA has been undertaking applied/contract research since 2001.

Professor Merlin is Chair of the Board of the International Network of Agencies for Health Technology Assessment (INAHTA) and co-chaired the INAHTA Quality Assurance Group for two years. She is the current Chair of the English Editorial Board of the international HTA Glossary and has been a member of Health Technology Assessment International (HTAi) since its inception.

Professor Merlin is a methodologist and clinical epidemiologist. In addition to publishing on methodological work, she has written over 150 systematic literature reviews, clinical practice guidelines and health technology assessment reports.

  • Team leaders

    Dr Shuhong Wang

    Team Leader, Pharmaceuticals

    Dr Shuhong Wang is responsible for evaluation of pharmaceutical industry submissions to the Pharmaceutical Benefits Advisory Committee. She has a PhD in Public Health (major in Health Economics) from the University of Adelaide, as well as a medical degree and a Masters in Medical Sciences from China. She is a health economist by training, with a background in epidemiology and experiences in economic modelling.

    David Tamblyn


    David Tamblyn

    AHTA Manager

    David Tamblyn has worked in the field of health technology assessment for over 10 years, and has experience evaluating pharmaceuticals, devices and medical services. He has been involved in HTA evaluations for both reimbursement and regulatory purposes, and in the development of national guidelines to inform the assessment of pharmaceuticals and medical services.

    Jacci Parsons


    Jacci Parsons

    Team Leader, Special Projects

    Jacci Parsons is an epidemiologist and public health researcher with close to 20 years' experience in systematic reviews. She began her training as a reviewer while working at the University of Oxford, and has conducted multiple systematic reviews for the Cochrane Library, and five for the World Health Organization. With over 10 years of service at AHTA, Jacci has been across a number of projects, including Horizon Scanning, systematic reviews to support clinical practice guidelines, systematic review development for TGA, NHMRC and the WHO, as well as actively contributing to teaching HTA and public health to undergraduate and postgraduate students at the University of Adelaide.

    Camille Schubert


    Camille Schubert

    Team Leader, Health Economics

    Camille Schubert is primarily involved in modelling health outcomes and costs associated with proposals for new listings on the Medicare Benefits Scheme, for the Medical Services Advisory Committee and supervision of the production of independent Commentaries for the Pharmaceutical Benefits Advisory Committee on applications made by industry to the Pharmaceutical Benefits Scheme. Her primary expertise is health economic policy associated with funding of health technologies, pharmacoeconomics and the economics of co-dependent health technologies.

    Skye Newton


    Skye Newton

    Team Leader, Medical HTA

    Skye Newton is a clinical epidemiologist who has 14 years' experience performing and providing guidance and quality assurance for evaluations for the Medical Services Advisory Committee (MSAC). Skye has strong expertise in the evaluation of investigative tests, in particular, genetic tests.

    Arlene Vogan

    Acting Team Leader, Health Economics

    Arlene Vogan is a senior health economist at Adelaide Health Technology Assessment (AHTA) and has worked in the field of HTA for 10 years. She is responsible for the production or evaluation of economic evaluations of medical services, pharmaceuticals and co-dependent technologies for the Medical Services Advisory Committee and/or the Pharmaceutical Benefits Advisory Committee.

  • Administration

  • Ethicist

  • Pharmaceutical evaluators

  • Healthcare & medical device evaluators

  • Health economists

  • Research IT

  • Students

  • Affiliates and consultants